Home/ Supplements/ Electrolytes/ PMS Relief

PMS Relief

product on market Capsule Signature Supplements Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 22% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains Black Cohosh and Dong Quai, which have limited evidence for managing menopausal and menstrual symptoms. Red Raspberry and Horsetail are included for general support, though clinical data for PMS relief is sparse. Overall, the evidence coverage for these specific ingredients is very low.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for PMS Relief
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
50
Servings
Botanical
Product Type
22%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

185 mg (19% DV)
Market median: 4002.0mg (1 products) 21 studies (A:0, B:2)
Horsetail
120 mg
115 mg
Market median: 80.0mg (136 products)
Dong Quai
115 mg
Red Raspberry
110 mg
Schizandra
105 mg
Chaste Berry
50 mg
30 mg
Market median: 300.0mg (214 products) 25 studies (A:0, B:6)
Papaya
50 mg

Other Ingredients

Cellulose Diatomaceous Earth
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: For adults, take two (2) capsules daily, more if needed.

Warnings & Precautions

As a reminder, discuss the supplements and medications you take with your health care providers.

Keep out of reach of children store in a dry place and avoid excessive heat.

Formulation Notes

No: Chemical Fillers or Binders, Artificial coloring, artificial flavor, preservatives, yeast, corn, milk or milk derivatives, lactose, salt, sodium, soy, sugar, gluten, starch or wheat.

From a GMP Facility

PMS Relief with Vitex & Schizandra

PMS Relief is designed to support normal hormone levels and menstrual cycles.

Additional Information

Keep out of reach of children store in a dry place and avoid excessive heat.

Metadata

Product Details

DSLD Entry Date2025-08-22
Product TypeBotanical
FormCapsule
DSLD ID338916
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.